Skip to main content

Table 1 Clinical data from TCGA patients

From: Prediction of chemo-response in serous ovarian cancer

  CR IR p-value*
Number of Patients 292 158  
Age (Avg.) 60 59.6 N.S.
Grade    N.S.
Grade 1 4 1  
Grade 2 35 18  
Grade 3 246 135  
Stage    p < 0.01
Stage I 10 3  
Stage II 19 1  
Stage III 224 123  
Stage IV 39 29  
Surgical outcome    N.S.
Optimal (<1 cm residual) 207 92  
Suboptimal (>1 cm residual) 52 57  
Optimal Treatment    p < 0.001
Optimal (Surgery + 6 cycles) 179 66  
Suboptimal 113 92  
  1. *Multivariable analysis of TCGA clinical variables: Only FIGO stage and optimal treatment (including optimal surgery AND 6 cycles of platinum-based chemotherapy) were independently associated with chemo-response in serous OVCA